Home > Insider Trading > Filing (0001104659-25-070104)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1377121	Protagonist Therapeutics Inc	PTGX	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1120477	D Ph V Dinesh Patel	C/O Protagonist Therapeutics, Inc. 7707 Gateway Blvd., Suite 140 Newark CA 94560-1160	President And Ceo	Yes	Yes	No	No

Transaction Summary

Sold:	52,444 shares	Avg. Price: $54.92	Total Value: $2,880,043.79
Number of Shares After Transactions:	531,018 shares

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-07-21	25,000	$0.00	583,462	No	4	A	Direct
Common Stock	Disposition	2025-07-21	12,859	$54.86	570,603	No	4	S	Direct
Common Stock	Disposition	2025-07-22	22,065	$55.05	548,538	No	4	S	Direct
Common Stock	Disposition	2025-07-23	17,520	$54.79	531,018	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents settlement by the Issuer of performance stock units ("PSUs") granted to the Reporting Person under the Issuer's 2016 Equity Incentive Plan on February 26, 2021, which vested based on the Issuer's achievement of corporate performance objectives.
Sale of shares to cover tax withholding obligation incurred upon settlement of PSUs.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.00 to $55.19. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $54.75 to $55.00. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.